mRNA |
tanespimycin:bortezomib (250:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.13 |
0.0004 |
mRNA |
selumetinib:tretinoin (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.13 |
0.0004 |
mRNA |
leptomycin B |
CTRPv2 |
pan-cancer |
AAC |
-0.11 |
0.0006 |
mRNA |
crizotinib:PLX-4032 (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.12 |
0.0006 |
mRNA |
GSK1120212 |
CTRPv2 |
pan-cancer |
AAC |
-0.17 |
0.0008 |
mRNA |
A-770041 |
GDSC1000 |
pan-cancer |
AAC |
0.19 |
0.001 |
mRNA |
selumetinib:GDC-0941 (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.12 |
0.001 |
mRNA |
AZD6244 |
CTRPv2 |
pan-cancer |
AAC |
-0.11 |
0.002 |
mRNA |
erlotinib:PLX-4032 (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.12 |
0.002 |
mRNA |
canertinib |
CTRPv2 |
pan-cancer |
AAC |
-0.11 |
0.002 |